Furthermore, because we used SH-SY5Y cells and observed increases in Ten-3 mRNA expression, our results are in agreement with the recent report of Szemes et al. (2018), which indicates that in neuroblastoma, Wnt3a acts as a differentiation factor (making the cancer less malignant). The gene discussed is TENM3; the disease is neuroblastoma.